Portfolio / Coley

Logo-Okapi.jpg

Coley Pharmaceutical Group discovers, develops and commercializes a new class of drugs that stimulate the human immune system to treat and prevent cancer, asthma, allergy and infectious diseases. The company was initially listed on NASDAQ and subsequently acquired by Pfizer.

Visit the website

Company

Coley

Fund

AlpInvest

Status

Realized

Team member

Harrold van Barlingen

Technology

Icons-Creteria_Medical-technologymedical-devices.png

Therapeutics